NCT04275232View on ClinicalTrials.gov

Allogenic Plasma Aliquots in the Treatment of Ligneous Conjunctivitis

PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Ligneous Conjunctivitis, Left Eye
Interventions
BIOLOGICAL

Allogenic plasma aliquots, a source of plasminogen

Plasma eye drops, a source of plasminogen

Trial Locations (1)

A1B 3V6

Memorial University of Newfoundland, St. John's

All Listed Sponsors
collaborator

Canadian Blood Services

OTHER

lead

Dorothy Bautista, MD

OTHER